Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma
about
Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancerCyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer.Identification of Serological Biomarkers for Early Diagnosis of Lung Cancer Using a Protein Array-Based Approach.Early detection of lung cancer by using an autoantibody panel in Chinese population.
P2860
Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum anti-CCNY autoantibody i ...... e nonsmall-cell lung carcinoma
@en
Serum anti-CCNY autoantibody i ...... nonsmall-cell lung carcinoma.
@nl
type
label
Serum anti-CCNY autoantibody i ...... e nonsmall-cell lung carcinoma
@en
Serum anti-CCNY autoantibody i ...... nonsmall-cell lung carcinoma.
@nl
prefLabel
Serum anti-CCNY autoantibody i ...... e nonsmall-cell lung carcinoma
@en
Serum anti-CCNY autoantibody i ...... nonsmall-cell lung carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Serum anti-CCNY autoantibody i ...... e nonsmall-cell lung carcinoma
@en
P2093
P2860
P304
P356
10.1155/2013/935943
P50
P577
2013-09-18T00:00:00Z